Allogene Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ALLO Nasdaq 8731 https://allogene.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Allogene Therapeutics Inc

Allogene Therapeutics Publishes Preclinical Data in Clinical Cancer Research Supporting DLL3 as a Potential AlloCAR T™ Target for Small Cell Lung Cancer - Jan 25th, 2023 1:30 pm
Allogene Therapeutics (ALLO) Soars 15.7%: Is Further Upside Left in the Stock? - Jan 25th, 2023 7:52 am
Allogene Therapeutics Announces Publication in Nature Medicine of Data from its Phase 1 UNIVERSAL Study of ALLO-715 for the Treatment of Relapsed/Refractory Multiple Myeloma - Jan 24th, 2023 1:30 pm
Jazz (JAZZ) Gastric Cancer Study Shows Improved Overall Survival - Jan 20th, 2023 6:00 pm
Is Immunocore (IMCR) Stock Outpacing Its Medical Peers This Year? - Jan 19th, 2023 2:40 pm
Moderna (MRNA) Up on Upbeat Data From Phase III Study on RSV Jab - Jan 18th, 2023 3:38 pm
Allogene Therapeutics Announces Participation in Two Upcoming Investor Conferences - Jan 17th, 2023 9:05 pm
Valneva (VALN) Stock Down 61.5% in the Past Year: Here's Why - Jan 16th, 2023 3:25 pm
Aprea (APRE) Rises on Advancing Lead Drug to Clinical Studies - Jan 12th, 2023 2:56 pm
Amarin's (AMRN) Q4 Preliminary Revenues Top Expectations - Jan 12th, 2023 12:14 am
Arvinas, Inc. (ARVN) Soars 10.3%: Is Further Upside Left in the Stock? - Jan 11th, 2023 1:35 pm
Emergent (EBS) to Start Restructuring Plan, Lays Off 5% Workforce - Jan 10th, 2023 5:06 pm
Moderna (MRNA) Reports 2023 Business View & Pipeline Updates - Jan 10th, 2023 4:55 pm
FDA Accepts AstraZeneca (AZN), Sanofi's RSV Antibody BLA - Jan 6th, 2023 6:50 pm
Allogene Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference - Jan 4th, 2023 1:30 pm
Allogene Appoints Zachary J. Roberts, M.D., Ph.D. as Executive Vice President of Research & Development - Jan 3rd, 2023 1:00 pm
Down -41.38% in 4 Weeks, Here's Why Allogene Therapeutics (ALLO) Looks Ripe for a Turnaround - Dec 29th, 2022 2:35 pm
15 Most Shorted Stocks Hedge Funds Are Buying - Dec 28th, 2022 5:32 pm
Wall Street Analysts Think Allogene Therapeutics (ALLO) Could Surge 159%: Read This Before Placing a Bet - Dec 8th, 2022 2:55 pm
Allogene Therapeutics (ALLO) Down 1.6% Since Last Earnings Report: Can It Rebound? - Dec 2nd, 2022 4:31 pm